Investments (#)
Investments (USD)
Transactions
Recent transactions in the sector
| Company | Country | Funding round | Date | |
|---|---|---|---|---|
|
Maven Clinic Co Women and family health virtual clinic. |
United States | Series F USD 125,000,000 (USD 125,000,000) at USD 1,700,000,000 (USD 1,700,000,000) valuation. |
8 Oct 2024 |
|
Judo Bio Inc Developer of oligonucleotide medicines delivered to the kidney. |
United States | Series A USD 100,000,000 (USD 100,000,000) |
7 Oct 2024 |
|
Doccla Ltd Provider of virtual ward and remote patient monitoring solutions. |
United Kingdom | Series B GBP 35,000,000 |
3 Sep 2024 |
|
Slingshot AI Mental health company. |
United States | Seed USD 30,000,000 (USD 30,000,000) |
22 Aug 2024 |
|
Bedal International NV |
Belgium | N/A USD 11,000,000 (USD 11,000,000) |
12 Jul 2024 |
|
Adona Medical Inc Developer of heart failure solutions. |
United States | Series C USD 33,500,000 (USD 33,500,000) |
11 Jul 2024 |
|
BillionToOne Inc Genetic testing platform detecting and measuring disease. |
United States | Series D USD 130,000,000 (USD 130,000,000) at USD 1,000,000,000 (USD 1,000,000,000) valuation. |
24 Jun 2024 |
|
Eden Health Inc Primary care and insurance navigation company. |
United States | Acquisition |
22 May 2024 |
|
Ajax Therapeutics Inc Blood cancer biotech. |
United States | Series C USD 95,000,000 (USD 95,000,000) |
13 May 2024 |
|
May Health Medical device company focused on endocrine disorder polycystic ovary syndrome. |
France | Series B USD 25,000,000 (USD 25,000,000) |
13 May 2024 |
|
ArkeaBio Corp Developer of a vaccine to reduce livestock methane emissions. |
United States | Series A USD 26,500,000 (USD 26,500,000) |
10 May 2024 |
|
Zephyr AI Inc Precision medicine startup. |
United States | Series A USD 111,000,000 (USD 111,000,000) |
13 Mar 2024 |
|
Ambience Healthcare Inc "AI operating system" for health care organisations. |
United States | Series B USD 70,000,000 (USD 70,000,000) |
6 Feb 2024 |
|
Via Scientific Inc Developer of a multi-omics platform. |
N/A USD 5,000,000 (USD 5,000,000) |
9 Jan 2024 | |
|
Calliditas Therapeutics AB Biopharma company focused on identifying, developing, and commercialising novel treatments in orphan indications with significant unmet medical needs. |
Sweden | Debt EUR 92,000,000 |
27 Dec 2023 |
|
Parse Biosciences Provider of single-cell sequencing solutions. |
United States | Series C USD 50,000,000 (USD 50,000,000) |
15 Dec 2023 |
|
|
Parse Biosciences Provider of single-cell sequencing solutions. |
United States | Debt |
15 Dec 2023 |
|
Vivodyne Inc Philadelphia-based biotech that tests its drug candidates on lab-grown human organs. |
United States | Seed USD 38,000,000 (USD 38,000,000) |
22 Nov 2023 |
|
|
Doccla Ltd Provider of virtual ward and remote patient monitoring solutions. |
United Kingdom | N/A |
21 Nov 2023 |
|
Atom Limbs Inc Innovator in prosthetic technology. |
Crowdfunding - Equity |
21 Nov 2023 | |
|
Healthtech-1 Ltd Automating repetitive processes in healthcare. |
United Kingdom | Seed |
2023 |
|
Midi Health Inc Virtual women's hormone care clinic. |
United States | Seed USD 14,000,000 (USD 14,000,000) |
31 Oct 2022 |
|
Brightline Inc Mental telehealth startup focused on young people. |
United States | Series C USD 105,000,000 (USD 105,000,000) at USD 600,000,000 (USD 600,000,000) valuation. |
30 Mar 2022 |
|
|
Doccla Ltd Provider of virtual ward and remote patient monitoring solutions. |
United Kingdom | Series A |
2022 |
|
Clinikally Digital Health Pvt Ltd India's telemedicine platform and online pharmacy for dermatology care. |
India | Seed |
2022 |
|
|
Atom Limbs Inc Innovator in prosthetic technology. |
Grant |
19 Dec 2021 | |
|
|
Atom Limbs Inc Innovator in prosthetic technology. |
Pre Seed |
22 Apr 2021 | |
|
Small Door Veterinary Veterinary care company. |
United States | Series A USD 20,000,000 |
21 Apr 2021 |
|
|
Parse Biosciences Provider of single-cell sequencing solutions. |
United States | N/A USD 7,000,000 (USD 7,000,000) |
27 Jan 2021 |
|
Maridose LLC Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs. |
United States | Pre Seed USD 150,000 (USD 150,000) |
1 Jan 2021 |
|
|
Doccla Ltd Provider of virtual ward and remote patient monitoring solutions. |
United Kingdom | Seed |
2021 |
|
Abalone Bio Antibody drug discovery. |
United States | Seed |
31 Dec 2020 |
|
Whisper.ai Inc Developer of hearing aids. |
United States | Series B USD 35,000,000 (USD 35,000,000) |
16 Oct 2020 |
|
|
Atom Limbs Inc Innovator in prosthetic technology. |
SAFE |
1 Apr 2020 | |
|
Modern Healthcare Inc |
United States | Series B USD 31,000,000 (USD 31,000,000) |
16 Jan 2020 |
|
Gilgamesh Pharmaceuticals Inc Novel psychedelic-Inspired therapeutics for treating mental illness. |
United States | Seed |
31 Dec 2019 |
|
Digi-Prex Online subscription pharmacy that deliver patients with chronic diseases their prescriptions. |
India | Seed USD 5,500,000 (USD 5,500,000) |
20 Sep 2019 |
|
Babylon Health Services Ltd |
United Kingdom | Series C USD 550,000,000 (USD 550,000,000) at USD 1,500,000,000 (USD 1,500,000,000) valuation. |
2 Aug 2019 |
|
Shire PLC |
Ireland | Acquisition |
8 Jan 2019 |
|
Auris Health Inc |
United States | Acquisition USD 3,400,000,000 (USD 3,400,000,000) at USD 3,400,000,000 (USD 3,400,000,000) valuation. |
2019 |
|
1life Healthcare Inc A healthcare company focuses on designing innovative health care solutions. |
United States | Series C USD 220,000,000 (USD 220,000,000) |
22 Aug 2018 |
|
|
Modern Healthcare Inc |
United States | Seed USD 2,300,000 (USD 2,300,000) |
15 Jun 2018 |
|
Cambridge Cancer Genomics Ltd CCG.ai empowers clinicians to make personalised treatment strategies. |
United Kingdom | Seed |
31 Dec 2017 |
|
Ginkgo Bioworks Inc DNA design company. |
United States | Series D USD 275,000,000 (USD 275,000,000) at USD 1,300,000,000 (USD 1,300,000,000) valuation. |
14 Dec 2017 |
|
Auris Surgical Robotics Inc |
United States | Venture USD 280,000,000 (USD 280,000,000) at USD 1,000,000,000 (USD 1,000,000,000) valuation. |
4 Aug 2017 |
|
4C Medical Technologies Inc Medical device company developing minimally invasive therapies for structural heart disease. |
United States | Convertible Note USD 8,000,000 (USD 8,000,000) |
19 Jul 2017 |
|
|
ABI Health |
India | Seed USD 1,500,000 (USD 1,500,000) |
8 Jun 2017 |
|
|
Babylon Health Services Ltd |
United Kingdom | Series B USD 47,000,000 (USD 47,000,000) at USD 200,000,000 (USD 200,000,000) valuation. |
25 Apr 2017 |
|
|
BillionToOne Inc Genetic testing platform detecting and measuring disease. |
United States | Seed |
2017 |
|
NBE-Therapeutics AG Biotech company focused on developing antibody-based treatments for cancer patients. |
Switzerland | Series B CHF 20,000,000 (USD 20,500,000) |
8 Nov 2016 |
Companies
Best funded companies in the sector
One of the best-known health-care brands in the world and offers one of the most comprehensive product portfolios in the ophthalmic industry.
Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.
A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss.
A healthcare company focuses on designing innovative health care solutions.
Medical device company that develops electrosurgical blade system for hospitals and clinics.
Philadelphia-based biotech that tests its drug candidates on lab-grown human organs.
Medical device company developing minimally invasive therapies for structural heart disease.
Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy.
Biotech company focused on developing antibody-based treatments for cancer patients.
Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases.
Focused on developing neurostimulation therapies based on Nerve Block for patients with chronic pain conditions
Investors
Top investors in the Healthcare sector
| Investor | Profile | Country | Investments | |
|---|---|---|---|---|
|
SV Health Investors LLP | 19 | ||
|
Y Combinator | American technology startup accelerator. | United States | 14 |
|
Essex Woodlands Health Ventures Inc | United States | 6 | |
|
Kleiner Perkins Caufield & Byers LLC | Venture capital firm. | United States | 5 |
|
Versant Ventures Management LLC | Venture capital firm focused on making investments in the healthcare and biotechnology industries. | United States | 5 |
|
Frazier Healthcare Ventures | Investment firm providing growth and venture capital to healthcare companies. | United States | 4 |
|
MPM Capital | United States | 4 | |
|
Prospect Venture Partners | Venture capital firm | United States | 4 |
|
Third Rock Ventures LLC | Venture capital firm focused on building healthcare companies | United States | 4 |
|
Khosla Ventures | Venture capital firm founded by Vinod Khosla. | United States | 4 |
|
Forbion Capital Partners Management Services BV | Netherlands | 4 | |
|
The Carlyle Group LP | United States | 4 | |
|
Adams Street Partners LLC | Private equity and venture capital fund of funds | United States | 4 |
|
ARCH Venture Partners LP | Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup | United States | 4 |
|
Beecken Petty O'Keefe & Co | Chicago-based private equity management firm investing in middle-market buyout transactions, recapitalizations, and growth platforms in healthcare | United States | 3 |
|
Triathlon Medical Ventures LLC | United States | 3 | |
|
Johnson & Johnson Innovation LLC | Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. | United States | 3 |
|
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland | 3 |
|
ePlanet Capital | United States | 3 | |
|
Perseus LLC | Merchant bank and private equity fund management company. | United States | 3 |
|
Venture Investors LLC | United States | 3 | |
|
New Leaf Venture Partners | United States | 3 | |
|
Sequoia Capital Operations LLC | Venture capital firm. | United States | 3 |
|
EDF Ventures | United States | 3 | |
|
BioEnterprise | United States | 3 | |
|
Novartis Services Inc | United States | 3 | |
|
Alta Partners LP | Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies. | United States | 3 |
|
Kaiser Permanente Ventures | The corporate venturing arm of Kaiser Permanente. | 3 | |
|
TVM Capital Corp | United States | 3 | |
|
Vivo Ventures LLC | United States | 3 | |
|
North Coast Angel Fund | United States | 3 | |
|
Venrock Associates | The venture capital arm of the Rockefeller Family. | United States | 3 |
|
CMEA Capital | United States | 2 | |
|
Viking Global Investors LP | 2 | ||
|
Waud Capital Partners LLC | United States | 2 | |
|
VantagePoint Capital Partners | Venture capital firm with investments in the cleantech, information technology, and healthcare sectors. | United States | 2 |
|
ProQuest Investments | United States | 2 | |
|
Blue Chip Venture Co | United States | 2 | |
|
Gilead Sciences Inc | A biopharmaceutical company that discovers, develops and commercializes therapeutics. | United States | 2 |
|
|
Cascade Investment LLC | The private investment vehicle of Bill Gates. | United States | 2 |
|
|
Cressey & Co | United States | 2 | |
|
|
Spray Venture Partners | United States | 2 | |
|
|
Glengary Ventures LLC | United States | 2 | |
|
The Sprout Group | Venture capital affiliate of Credit Suisse | United States | 2 |
|
General Electric Co | United States | 2 | |
|
Athenian Venture Partners | Venture capital firm specializing in early stage investments in information technology, healthcare and digital health. | United States | 2 |
|
Baillie Gifford | Independent investment manager based in Edinburgh, investing globally on behalf of its clients. | United Kingdom | 2 |
|
Bioeconomy Capital | United States | 2 | |
|
Western Technology Investment | Venture debt firm investing debt and equity capital in venture-backed technology, healthcare and clean technology companies. | United States | 2 |
|
JumpStart Inc | United States | 2 |
Acquirers
Top acquirers in the Healthcare sector
| Investor | Profile | Country | Acquisitions | |
|---|---|---|---|---|
|
Abbott Laboratories | United States | 3 | |
|
Pfizer Inc | United States | 2 | |
|
Medtronic Inc | Medical technology company specializing in implantable and invasive therapies. | United States | 2 |
|
Johnson & Johnson Corp | 2 | ||
|
Takeda Pharmaceutical Co Ltd | 2 | ||
|
Roche Holding AG | 2 | ||
|
Eli Lilly & Co | 2 | ||
|
Centivo Corp | Health plan for self-funded employers. | 1 | |
|
|
Shire PLC | Ireland | 1 | |
|
|
Mallinckrodt | United States | 1 | |
|
Abbvie Inc | United States | 1 | |
|
|
BioMarin Pharmaceutical Inc | United States | 1 | |
|
|
Fresenius Medical Care | 1 | ||
|
|
Viatris | 1 | ||
|
Amgen Inc | United States | 1 | |
|
TC Group LLC | A global alternative asset manager investing across three asset classes - private equity, real estate and credit alternatives | United States | 1 |
|
Ampersand Ventures | United States | 1 | |
|
|
Valeant Pharmaceuticals International | 1 | ||
|
Nestlé SA | Switzerland | 1 | |
|
Bayer AG | Germany | 1 |
Industry map
Healthcare industry map
Valuations
Healthcare selected pre-money valuations (USD)
| Funding round | Median | Average | Minimum | Maximum | Sample size |
|---|---|---|---|---|---|
| Series B | 200,000,000 | 200,000,000 | 200,000,000 | 200,000,000 | 1 |
| Series C | 1,050,000,000 | 1,050,000,000 | 600,000,000 | 1,500,000,000 | 2 |
| Series D | 1,150,000,000 | 1,150,000,000 | 1,000,000,000 | 1,300,000,000 | 2 |
| Series F | 1,700,000,000 | 1,700,000,000 | 1,700,000,000 | 1,700,000,000 | 1 |
| Venture | 1,000,000,000 | 1,000,000,000 | 1,000,000,000 | 1,000,000,000 | 1 |
| Acquisition | 6,366,810,000 | 12,908,224,091 | 113,000,000 | 68,000,000,000 | 22 |
| 113,000,000 | 68,000,000,000 | 29 |
Healthcare selected deal sizes (USD)
| Funding round | Median | Average | Minimum | Maximum | Sample size |
|---|---|---|---|---|---|
| Convertible Note | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 1 |
| Pre Seed | 150,000 | 150,000 | 150,000 | 150,000 | 1 |
| Seed | 9,750,000 | 15,216,667 | 1,500,000 | 38,000,000 | 6 |
| Series A | 25,750,000 | 41,418,750 | 350,000 | 111,000,000 | 8 |
| Series B | 25,000,000 | 27,587,273 | 4,000,000 | 70,000,000 | 11 |
| Series C | 100,000,000 | 164,785,714 | 33,500,000 | 550,000,000 | 7 |
| Series D | 130,000,000 | 148,333,333 | 40,000,000 | 275,000,000 | 3 |
| Series E | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 1 |
| Series F | 125,000,000 | 125,000,000 | 125,000,000 | 125,000,000 | 1 |
| Venture | 16,500,000 | 70,300,000 | 12,000,000 | 280,000,000 | 5 |
| Acquisition | 5,600,000,000 | 12,351,996,957 | 113,000,000 | 68,000,000,000 | 23 |
| N/A | 9,500,000 | 20,000,000 | 5,000,000 | 65,000,000 | 6 |
| 73 |